Latest News in the pharma Industry

Top Stories

BASF Announces Record Increase in Sales

BASF Announces Record Increase in Sales

27 Feb 2012

BASF posted the fourth-quarter results last Friday and reported a record increase in sales which rose to €73.5bn in 2011.

Read more 
Merck Announces Efficiency Program

Merck Announces Efficiency Program

27 Feb 2012

The planned efficiency measures are part of the Group’s comprehensive transformation program.

Read more 
Lanthio Grants Tarix Exclusive License to Agonistic Peptide

Lanthio Grants Tarix Exclusive License to Agonistic Peptide

24 Feb 2012

Lanthio Pharma has granted Tarix Pharmaceuticals an exclusive license to its lanthionine-stabilized Angiotensin-(1-7) agonistic peptide for the treatment of acute lung injury.

Read more 
Auxilium & Actelion Enter Agreement for Xiaflex

Auxilium & Actelion Enter Agreement for Xiaflex

24 Feb 2012

Actelion will pay Auxilium $10 million upfront and will also make up to $16 million in potential regulatory, pricing, and reimbursement milestone payments and $42.5 million in potential sales milestone payments.

Read more 
Dako Forms Diagnostic Alliance with Amgen

Dako Forms Diagnostic Alliance with Amgen

23 Feb 2012

Dako announced a new collaboration agreement with Amgen on the development of a diagnostic test for an Amgen cancer drug candidate in clinical development.

Read more 
Bactiguard & Cadila Sign Distribution Agreement

Bactiguard & Cadila Sign Distribution Agreement

23 Feb 2012

Cadila Pharmaceuticals will sell the entire line of Bactiguard?s products throughout India.

Read more 
Boehringer Ingelheim & Xencor Ink Biosuperiors Pact

Boehringer Ingelheim & Xencor Ink Biosuperiors Pact

23 Feb 2012

Xencor and Boehringer Ingelheim have entered into a new alliance on the development of new biosuperior monoclonal antibodies.

Read more 
Enanta Signs License Agreement with Novartis

Enanta Signs License Agreement with Novartis

22 Feb 2012

Novartis will be responsible for all costs associated with the development, manufacture and commercialization of EDP-239 and will fund Enanta's drug discovery efforts on certain additional compounds targeting NS5A.

Read more 
Sigma Life Science Obtains Global License for Kyoto University's iPS Cell Patent Portfolio

Sigma Life Science Obtains Global License for Kyoto University's iPS Cell Patent Portfolio

22 Feb 2012

Sigma Life Science has acquired a worldwide license to use Kyoto University's induced pluripotent stem (iPS) cell patent portfolio.

Read more 
Johnson & Johnson Names Alex Gorsky CEO Effective April 26, 2012

Johnson & Johnson Names Alex Gorsky CEO Effective April 26, 2012

22 Feb 2012

Mr. Gorsky succeeds Bill Weldon, who has served as Chairman and CEO of Johnson & Johnson since 2002.

Read more 
DPT Laboratories Appoints R&D VP

DPT Laboratories Appoints R&D VP

22 Feb 2012

Dr. Bhatia will lead the research and pharmaceutical development group and oversee DPT's Center of Excellence for R&D in San Antonio.

Read more 
Brenntag Launches New Head Office in India

Brenntag Launches New Head Office in India

21 Feb 2012

The German chemicals distributor's new head office will provide room for the firm’s planned growth in India over the next few years.

Read more